OF

OFSA3

Ouro Fino Saúde Animal Participações S.A.
HealthcareBRL
R$25.141.53%
Last update: --:--

Report (Preview)

Detailed and complete analysis about this company
This report is not an investment recommendation. It is a study of the company.

Access full B3 reports

Full analysis — OFSA3 is available only for Premium subscribers.

With Premium you have access to detailed reports of all companies, with valuation and fair price.

Price Chart

Data provided by TradingView

Loading chart...

Valuation Multiples

Enterprise Value
R$1.50B
EV/EBITDA
4.96x
Cheap
EV/Revenue
1.1x
Forward P/E
12.09x
Fair
P/S (Price/Sales)
0.99x
Current P/E
5.73x

Margins & Profitability

Gross Margin52%
Operating Margin16.3%
Net Margin17.3%
EBITDA Margin22.2%
ROA
12%
Return on Assets
ROE
31.8%
Return on Equity

Growth

Revenue Growth
(YoY)
↑+30.7%
Earnings Growth
(YoY)
↓-22.8%
Quarterly Earnings
(QoQ)
↓-22.8%

Corporate Risk

Beta
Volatility vs market
0.30
Less volatile

Dividends

Dividend Yield
5.13%
Payout Ratio
29.38%
Low Payout
Annual DY$1.29
Avg 5Y DY
1.52%+3.6 pp
Last Ex-DateApr 17, 2026

Moving Averages

50-day average
Short term
$27.07
↓ Below
200-day average
Long term
$27.52
↓ Below
Death Cross (bearish signal)

Average Volume

10 days
6.3K
3 months
4.9K
Trend+29.1%

Dividend History (12m)

Total last 12 months:R$1.29

Price Evolution (12m)

R$25.14+13.71%
Nov 25Last 12 monthsNov 26

Seasonality Study

Historical monthly performance of the asset over the last 11 years. Helps identify seasonal behavior patterns.

11 Years analyzed

Avg Return (%)

High Frequency (%)

Best Month

Dec+5.8%

2nd Best

Nov+5.0%

High Frequency

Nov70%

High Frequency

Dec70%

Balance Sheet

PeriodTotal AssetsLiabilitiesTotal Equity
2025R$1.57BR$769MR$797M
2024R$1.38BR$628MR$756M
2023R$1.28BR$590MR$689M
2022R$1.35BR$611MR$736M

MyHub Discussion (0)

About the Company

Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including anti-inflammatories, antibiotics, anticoccidials, antimastitics, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, therapeutics, products for animal reproduction, and vaccines; and performance-enhancing additives, probiotics, and other veterinary products for cattle, swine, poultry, sheep, horses, and goats, as well as manufacturing services. The company also manufactures veterinary solutions for dogs and cats, such as anesthetics, sedatives, anti-inflammatory, antibiotic, antimicrobial, dermatological, ectoparasiticide, endoparasiticide, dermocosmetic, and otological products. In addition, it offers vaccines and other veterinary products for production and companion animals. The company was formerly known as A.H.N.S.P.E. Empreendimentos e Participações S.A. Ouro Fino Saúde Animal Participações S.A. was incorporated in 1987 and is headquartered in Cravinhos, Brazil.

Market Data

  • Market CapR$1.35B
  • Min 52sMax 52s
    R$22.11R$34.69
  • Average Volume23.8K

Search Another Asset

Recently Viewed

Log in to see your recent history.Log In